Dr de Azambuja talks with ecancer at the ESMO 2017 Congress about the data presented by Dr Angelo Di Leo from the MONARCH 3 trial looking at abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer. For more information...
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wi1dac
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,